Wockhardt rises as its arm gets approval for Oxycodone Hydrochloride Oral Solution

19 Jun 2015 Evaluate

Wockhardt is currently trading at Rs. 1398.20, up by 2.20 points or 0.16% from its previous closing of Rs. 1396.00 on the BSE.

The scrip opened at Rs. 1415.00 and has touched a high and low of Rs. 1419.45 and Rs. 1389.00 respectively. So far 131520 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2000.00 on 08-Apr-2015 and a 52 week low of Rs. 543.10 on 10-Jul-2014.

Last one week high and low of the scrip stood at Rs. 1419.45 and Rs. 1301.30 respectively. The current market cap of the company is Rs. 15354.07 crore.

The promoters holding in the company stood at 74.48% while Institutions and Non-Institutions held 11.53% and 13.86% respectively.

Wockhardt Bio AG, a subsidiary of Wockhardt, has reportedly received approval from US FDA for its abbreviated new drug application (ANDA) for Oxycodone Hydrochloride Oral Solution USP, 5 mg/5 mL. The Oxycodone Hydrochloride Oral Solution USP, 5 mg/5 mL, is bioequivalent and, therefore, therapeutically equivalent to the reference listed drug product (RLD), Oxycodone Hydrocodone Oral Solution, USP 5 mg/5 mL, of VistaPharm, Inc.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1357.80 18.05 (1.35%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×